These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2335375

  • 1. Generalized toxicity of L-leucyl-leucine-methyl ester for lymphocyte functions.
    Mowat AM, Leck PA.
    Immunology; 1990 Apr; 69(4):564-9. PubMed ID: 2335375
    [Abstract] [Full Text] [Related]

  • 2. Lethal graft-vs-host disease across major histocompatibility barriers: requirement for leucyl-leucine methyl ester sensitive cytotoxic T cells.
    Thiele DL, Charley MR, Calomeni JA, Lipsky PE.
    J Immunol; 1987 Jan 01; 138(1):51-7. PubMed ID: 2946780
    [Abstract] [Full Text] [Related]

  • 3. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes.
    Thiele DL, Lipsky PE.
    J Immunol; 1986 Feb 01; 136(3):1038-48. PubMed ID: 2934477
    [Abstract] [Full Text] [Related]

  • 4. Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells.
    Thiele DL, Bryde SE, Lipsky PE.
    J Immunol; 1988 Nov 15; 141(10):3377-82. PubMed ID: 3053897
    [Abstract] [Full Text] [Related]

  • 5. Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets.
    Thiele DL, Lipsky PE.
    J Immunol; 1986 Aug 15; 137(4):1399-406. PubMed ID: 3488348
    [Abstract] [Full Text] [Related]

  • 6. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL, Calomeni JA, Lipsky PE.
    J Immunol; 1987 Oct 01; 139(7):2137-42. PubMed ID: 3309052
    [Abstract] [Full Text] [Related]

  • 7. Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells.
    Thiele DL, Lipsky PE.
    J Immunol; 1985 Feb 01; 134(2):786-93. PubMed ID: 3965574
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of leucyl-leucine methyl ester-sensitive cytotoxic cells in skin allograft rejection.
    Thiele DL, Geissler GH, Williams FH, Lipsky PE.
    Transplantation; 1992 Jun 01; 53(6):1334-40. PubMed ID: 1604489
    [Abstract] [Full Text] [Related]

  • 11. Immunological studies of NK cell-deficient beige mice. II. Analysis of T-lymphocyte functions in beige mice.
    Baca ME, Mowat AM, Parrott DM.
    Immunology; 1989 Jan 01; 66(1):131-7. PubMed ID: 15493275
    [Abstract] [Full Text] [Related]

  • 12. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
    Moser M, Sharrow SO, Shearer GM.
    J Immunol; 1988 Apr 15; 140(8):2600-8. PubMed ID: 3258615
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
    Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH.
    J Immunol; 1986 Jun 15; 136(12):4480-6. PubMed ID: 3086432
    [Abstract] [Full Text] [Related]

  • 17. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU, Bosslet K, Dickneite G, Lüben G, Sedlacek HH.
    Behring Inst Mitt; 1984 May 15; (74):157-73. PubMed ID: 6383322
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS, Niederkorn JY.
    J Immunol; 1986 Jun 15; 136(12):4362-71. PubMed ID: 3519767
    [Abstract] [Full Text] [Related]

  • 20. GVHR elicited by products of class I or class II loci of the MHC: analysis of the response of mouse T lymphocytes to products of class I and class II loci of the MHC in correlation with GVHR-induced mortality, medullary aplasia, and enteropathy.
    Piguet PF.
    J Immunol; 1985 Sep 15; 135(3):1637-43. PubMed ID: 2410497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.